Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03208816 · ClinicalTrials.gov registry record · NA
Community-Led Action Research in Oncology: Improving Symptom Management
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03208816 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 25 participants.
The verdict
NCT03208816, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will be conducted at La Liga Contra el Cancer in San Pedro Sula, Honduras. The overall objective of this project is to improve symptom management for patients undergoing chemotherapy in Honduras. The first step in this line of research is a "proof of concept" feasibility study in which the investigators will demonstrate their ability to train nurses to administer a non-pharmacological, telephone-delivered, symptom management program for chemotherapy patients.
Interventions
- BEHAVIORAL symptom management program for chemotherapy patients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-07-24 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03208816
The ClinicalTrials.gov registry entry for NCT03208816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which symptom management program for chemotherapy patients is the first listed.
NCT03208816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03208816 about?
NCT03208816 is a clinical study titled "Community-Led Action Research in Oncology: Improving Symptom Management". This study will be conducted at La Liga Contra el Cancer in San Pedro Sula, Honduras. The overall objective of this project is to improve symptom management for patients undergoing chemotherapy in Honduras. The first step in this line of research is a "proof of concept" feasibility study in which th...
What is the current status of trial NCT03208816?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2017-07-24. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT03208816?
The interventions under investigation include: symptom management program for chemotherapy patients (BEHAVIORAL).
Who is sponsoring clinical trial NCT03208816?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.